Related Experiment Video
Updated: Aug 30, 2025
06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
353
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient
Jesse G Dixon1, Çağlar Çağlayan2, Dai Chihara3
1Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Clinical Lymphoma, Myeloma & Leukemia
|August 31, 2022
Summary
This study analyzed follicular lymphoma (FL) patient data to identify factors influencing outcomes. CD20-targeting agents significantly improved progression-free survival and reduced FL-related mortality.
Area of Science:
- Hematology
- Oncology
- Clinical Trials
Background:
- Follicular lymphoma (FL) is an indolent non-Hodgkin lymphoma.
- Understanding factors influencing FL patient outcomes after first-line therapy is crucial for personalized treatment strategies.
Purpose of the Study:
- To investigate clinical factors associated with follicular lymphoma (FL) outcomes.
- To analyze the impact of CD20-targeting agents on FL progression and mortality.
Main Methods:
- Utilized the Follicular Lymphoma Analysis of Surrogacy Hypothesis database of 2428 patients from 8 first-line clinical trials.
- Employed multistate survival models, Aalen-Johansen estimator, and Cox models to assess outcomes and predictor effects.
Main Results:
- Male sex, >4 involved nodal areas, elevated LDH, low hemoglobin, and elevated β-2 levels were associated with increased progression risk.
- CD20-targeting agents significantly reduced risks for progression, FL-related death, and other causes of death.
- Estimated 2-year progression rates were 22.3% with CD20 agents vs. 43.5% without; FL-associated mortality was 8.3% without CD20 agents.
Conclusions:
- Baseline clinical factors independently contribute to distinct FL outcomes post-first-line therapy.
- CD20-targeting agents demonstrate a substantial benefit in improving outcomes for FL patients.
- Further research employing similar analytical approaches is needed to enhance understanding of FL outcome determinants in diverse settings.
Related Concept Videos
01:21Cancer Survival Analysis
432
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
432
01:20Comparing the Survival Analysis of Two or More Groups
264
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
264
01:15Assumptions of Survival Analysis
178
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
178
01:18Introduction To Survival Analysis
359
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
359
01:20Actuarial Approach
119
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
119
01:24Kaplan-Meier Approach
237
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
237